XLO Xilio Therapeutics, Inc.

Fundamentals / CIK 0001840233 / USD

Xilio Therapeutics, Inc. reported $55.01M in revenue and a net loss of $11.49M for the trailing twelve months ended September 30, 2026 (down 47.6% year over year), with a -74.9% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open XLO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$52.45M$26.23M$0-$86.21MFY 2020 Net Income: -$55.22M2020FY 2021 Net Income: -$75.80M2021FY 2022 Net Income: -$88.22M2022FY 2023 Net Income: -$76.40M2023FY 2024 Revenue: $6.34MFY 2024 Net Income: -$58.24M2024FY 2025 Revenue: $43.77MFY 2025 Net Income: -$35.04M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $43.77M $6.34M -- -- -- --
Research & Development $56.04M $41.21M $52.14M $59.20M $51.19M $43.91M
Total Operating Expenses $85.75M $66.93M $79.13M $89.15M $75.04M $54.56M
Operating Income -$41.98M -$60.58M -$79.13M -$89.15M -$75.04M -$54.56M
EBITDA -$40.44M -$58.94M -$77.23M -$87.30M -$73.55M -$53.50M
Income Before Tax -$35.04M -$58.24M -- -- -- --
Income Tax Expense $0 $0 $0 $0 $0 $0
Net Income -$35.04M -$58.24M -$76.40M -$88.22M -$75.80M -$55.22M
Basic EPS -$4.19 -$15.24 -$38.94 -$45.10 -$189.36 -$1,476.47
Diluted EPS -$4.19 -$15.24 -$38.94 -$45.10 -$189.36 -$1,476.47
Basic Shares Outstanding 8.4M 3.8M 2.0M 2.0M 400.3K 37.4K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $9.98M $18.69M $12.65M $13.69M $19.07M $8.08M $2.93M --
Research & Development $14.80M $14.56M $19.83M $18.12M $14.32M $15.33M $8.27M $8.84M
Total Operating Expenses $21.73M $22.18M $26.76M $25.52M $21.00M $22.45M $16.78M $15.35M
Operating Income -$11.75M -$3.49M -$14.11M -$11.84M -$1.93M -$14.37M -$13.85M -$13.63M
EBITDA -$11.43M -$3.16M -$13.77M -$11.51M -$1.59M -$13.98M -$13.35M -$13.25M
Net Income -$5.95M -$6.37M -$9.53M $10.36M -$16.29M -$15.84M -$13.27M -$13.09M
Basic EPS -$0.30 -$0.33 -$0.58 -- -$1.58 -$2.30 -$2.49 --
Diluted EPS -$0.30 -$0.33 -$0.58 -- -$1.58 -$2.30 -$2.49 --
Basic Shares Outstanding 19.7M 19.4M 16.3M -- 10.3M 6.9M 5.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $137.5M $55.29M $44.70M $120.4M $198.1M $19.24M
Cash & Short-Term Investments $137.5M $55.29M $44.70M $120.4M $198.1M $19.24M
Other Current Assets -- -- -- -- -- $44K
Total Current Assets $145.0M $60.23M $48.13M $124.5M $202.5M $20.59M
Property, Plant & Equipment, Net $3.89M $4.47M $5.94M $7.25M $7.62M $7.37M
Other Non-Current Assets -- -- $145K $267K $393K $500K
Total Non-Current Assets $9.66M $10.84M $12.80M $14.67M $15.54M $15.73M
Total Assets $154.7M $71.08M $60.93M $139.2M $218.1M $36.32M
Accounts Payable $3.17M $2.57M $1.05M $3.12M $3.14M $5.44M
Deferred Revenue (Current) $40.02M $13.52M -- -- -- --
Other Current Liabilities -- -- $48K $82K $82K $82K
Total Current Liabilities $56.27M $27.26M $15.96M $21.12M $12.78M $22.16M
Deferred Revenue (Non-Current) $20.64M $19.26M -- -- -- --
Other Non-Current Liabilities -- -- -- $45K $118K $1.13M
Total Non-Current Liabilities $63.14M $26.22M $8.14M $12.40M $19.85M $19.45M
Total Liabilities $119.4M $53.48M $24.10M $33.52M $32.63M $41.60M
Total Debt (incl. Leases) $6.95M $8.14M $9.24M $10.23M $11.11M $11.74M
Common Stock $0 $5.0K $3.0K $3.0K $3.0K --
Retained Earnings -$418.8M -$383.8M -$325.5M -$249.1M -$160.9M -$85.09M
Total Stockholders' Equity $35.27M $17.60M $36.83M $105.6M $185.4M -$83.29M
Total Equity $35.27M $17.60M $36.83M $105.6M $185.4M -$83.29M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $122.2M $136.0M $150.3M $137.5M $103.8M $121.6M $89.07M $55.29M
Cash & Short-Term Investments $122.2M $136.0M $150.3M $137.5M $103.8M $121.6M $89.07M $55.29M
Total Current Assets $126.5M $145.5M $154.2M $145.0M $124.1M $123.7M $93.20M $60.23M
Property, Plant & Equipment, Net $3.09M $3.36M $3.68M $3.89M $3.68M $4.02M $4.29M $4.47M
Total Non-Current Assets $8.33M $8.79M $9.28M $9.66M $9.61M $10.10M $10.52M $10.84M
Total Assets $134.8M $154.3M $163.5M $154.7M $133.7M $133.8M $103.7M $71.08M
Accounts Payable $753K $2.31M $1.06M $3.17M $2.30M $4.10M $2.27M $2.57M
Deferred Revenue (Current) $15.41M $22.60M $31.54M $40.02M $43.85M $42.28M $40.25M $13.52M
Total Current Liabilities $26.80M $34.20M $42.96M $56.27M $56.40M $53.26M $47.64M $27.26M
Deferred Revenue (Non-Current) $9.93M $12.71M $16.47M $20.64M $25.50M $28.63M $38.74M $19.26M
Total Non-Current Liabilities $39.80M $47.79M $47.98M $63.14M $85.39M $73.48M $45.38M $26.22M
Total Liabilities $66.60M $81.99M $90.94M $119.4M $141.8M $126.7M $93.02M $53.48M
Total Debt (incl. Leases) $5.96M $6.30M $6.64M $6.95M $7.26M $7.57M $7.86M $8.14M
Common Stock $1.0K $1.0K $1.0K $0 $5.0K $5.0K $5.0K $5.0K
Retained Earnings -$440.6M -$434.7M -$428.3M -$418.8M -$429.1M -$412.9M -$397.0M -$383.8M
Total Stockholders' Equity $68.23M $72.26M $72.55M $35.27M -$8.10M $7.07M $10.70M $17.60M
Total Equity $68.23M $72.26M $72.55M $35.27M -$8.10M $7.07M $10.70M $17.60M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$35.04M -$58.24M -$76.40M -$88.22M -$75.80M -$55.22M
Depreciation & Amortization $1.54M $1.64M $1.90M $1.85M $1.50M $1.06M
Stock-Based Compensation $6.94M $6.43M $7.38M $8.42M $4.96M $1.30M
Change in Receivables -$5.00M -- -- -- -- --
Change in Payables $152K $1.53M -$2.06M $485K -$2.82M $2.93M
Operating Cash Flow -$4.99M -$18.38M -$68.62M -$75.72M -$80.75M -$36.09M
Capital Expenditure -$518K -$36K -$486K -$1.87M -$1.10M -$2.19M
Free Cash Flow -$5.51M -$18.41M -$69.11M -$77.59M -$81.85M -$38.28M
Investing Cash Flow -$518K -$36K -$486K -$1.87M -$1.10M -$2.19M
Common Stock Issued -- -- -- -- $116.4M --
Financing Cash Flow $87.78M $29.20M -$6.55M -$69K $260.7M $10.03M
Net Change in Cash $82.27M $10.78M -$75.66M -$77.66M $178.8M -$28.25M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$5.95M -$6.37M -$9.53M $10.36M -$16.29M -$15.84M -$13.27M -$13.09M
Depreciation & Amortization $321K $331K $344K $323K $340K $381K $497K $376K
Stock-Based Compensation $1.92M $1.60M $2.21M $2.93M $1.12M $1.35M $1.53M $1.52M
Change in Receivables $6.00M -$6.00M $5.00M $12.50M -- -- $0 --
Change in Payables -$1.55M $1.26M -$1.68M $428K -$1.80M $2.11M -$590K $1.60M
Operating Cash Flow -$13.79M -$18.76M -$22.34M -$2.00M -$17.50M -$14.48M $28.98M -$14.16M
Capital Expenditure -$58K -$19K -$556K -$95K $0 -$401K -$22K --
Free Cash Flow -$13.85M -$18.78M -$22.90M -$2.09M -$17.50M -$14.88M $28.96M --
Investing Cash Flow -$58K -$19K -$556K -$95K $0 -$401K -$22K --
Financing Cash Flow $0 $4.49M $35.71M $35.87M -$285K $47.36M $4.83M $8.20M
Net Change in Cash -$13.85M -$14.29M $12.81M $33.77M -$17.78M $32.48M $33.79M -$5.96M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -95.9% -954.9% -- -- -- --
Net Profit Margin -80.1% -918.0% -- -- -- --
Return on Equity (ROE) -99.3% -331.0% -207.5% -83.5% -40.9% --
Return on Assets (ROA) -22.6% -81.9% -125.4% -63.4% -34.8% -152.0%
Current Ratio 2.58x 2.21x 3.02x 5.89x 15.85x 0.93x
Quick Ratio 2.44x 2.03x 2.80x 5.70x 15.50x 0.87x
Debt to Equity 0.20x 0.46x 0.25x 0.10x 0.06x --
Revenue Growth (YoY) +589.9% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -74.9% -48.9% -79.0% -95.9% -- -- -- --
Net Profit Margin -20.9% -34.1% -58.5% -80.1% -- -- -- --
Return on Equity (ROE) -16.8% -30.2% -43.1% -99.3% -- -795.3% -507.5% -331.0%
Return on Assets (ROA) -8.5% -14.2% -19.1% -22.6% -43.7% -42.0% -52.4% -81.9%
Current Ratio 4.72x 4.25x 3.59x 2.58x 2.20x 2.32x 1.96x 2.21x
Quick Ratio 4.56x 3.98x 3.50x 2.44x 1.84x 2.28x 1.87x 2.03x
Debt to Equity 0.09x 0.09x 0.09x 0.20x -- 1.07x 0.73x 0.46x
Revenue Growth (YoY) -47.6% +131.2% +331.7% -- +742.5% +243.0% -- --
Operating Cash Flow Growth (YoY) -- -- -177.1% -- -- -172.6% -- --
Free Cash Flow Growth (YoY) -- -- -179.1% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001840233) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:52 UTC · Open in terminal